Cytokinetics to Participate in November Investor Conferences
Key Highlights
- ➤Cytokinetics (CYTK) announces four November investor conference fireside chats
- ➤Aficamten nHCM supplemental New Drug Application planned for Q4 2026
- ➤MYQORZO (aficamten) approved in five markets for symptomatic obstructive HCM
- ➤Webcast replays will remain archived on Cytokinetics’ website for 90 days
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences in November: * Stifel 2026 Healthcare Conference: Fireside chat on Tuesday, November 10, 2026 at 1:20 PM Eastern Time in New York, NY. * UBS Global Biopharma Conference 2026: Fireside chat on Monday, November 16, 2026 at 10:40 AM Greenwich Mean Time in London, England. * Jefferies Global Healthcare Conference: Fireside chat on Tuesday, November 17, 2026 at 11:00 AM Greenwich Mean Time in London, England. * 9(th) Annual Evercore Healthcare Conference: Fireside chat on Monday, November 30, 2026 at 3:00 PM Eastern Time in Coral Gables, FL. Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com. The webcast replays will be archived on the Cytokinetics website for 90 days following the conclusion of the event.
Get started
Create a free account to read the full story.